ApolloMed Q3 revenue $348.2M (+10% YoY), EPS $0.47; acquires CFC for ~$202M

Astrana Health, Inc.

2023-Q3 EPS reported $1.03 revenue$1,033,625,000

Total revenue $348.2M (+10% YoY); net income $22.1M ($0.47 diluted EPS) vs $23.2M ($0.50).
Adjusted EBITDA $52.0M (15% margin) vs $57.1M; full-year guidance narrowed to $1.34-1.39B revenue.
Agreed to acquire Community Family Care (200k+ members) for ~$202M cash/equity; expected close Q1 2024.
Entered $300M term loan amendment to expand credit facility to $700M; $100M stock repurchase from APC.
Partnerships: Associated Hispanic Physicians (~25k members), Advantage Health Network, Wider Circle CalAIM.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Astrana Health, Inc. reported third quarter ended September 30, 2023 results: revenue $348.2 million, net income $22.1 million, EPS $0.47.

Period: third quarter ended September 30, 2023
Revenue: $348.2 million
Net income: $22.1 million
EPS: $0.47
Result: reported results

Exact text from the filing

ahead.” Financial Highlights for Third Quarter Ended September 30, 2023: All comparisons are to the quarter ended September 30, 2022 unless otherwise stated. · Total revenue of $348.2 million, up 10% from $317.0 million · Care Partners revenue of $326.5 million, up 11% from $293.6 million · Net income attributable to ApolloMed of $22.1 million, compared to $23.2

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Astrana Health, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-115263

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.